| 产品描述: | RORγt Inverse agonist 3 is a potent, selective and orally active RORγ inverse agonist, with EC50s of 0.22 μM and 0.15 μM for hRORγ and RORγt (human IL-17 cells), respectively. |
| 靶点: |
EC50: 0.22 μM (hRORγ), 0.15 μM (RORγt, human IL-17 cells) |
| 参考文献: |
1. Amaudrut J, et al. Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists. Bioorg Med Chem Lett. 2019 Jul 15;29(14):1799-1806. |
| 保存条件: |
-80°C 12个月; -20°C 6个月,干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.622 ml |
8.11 ml |
16.219 ml |
| 5 mM |
0.324 ml |
1.622 ml |
3.244 ml |
| 10 mM |
0.162 ml |
0.811 ml |
1.622 ml |
| 50 mM |
0.032 ml |
0.162 ml |
0.324 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |